Beximco Pharmaceuticals Plc's next confirmed earnings release is scheduled for December 2, 2026.
| Earnings Date | 12/2/2026 |
As of the close on October 19, 2026, Beximco Pharmaceuticals Plc's stock has gained approximately 36.55% over the past 52 weeks. The 50-day moving average sits at 146.63, while the 200-day moving average is 129.46.
| 52-Week Price Change | 36.55% |
| 50-Day Moving Average | 146.63 |
| 200-Day Moving Average | 129.46 |
Beximco Pharmaceuticals Plc's most recent stock split took place on November 26, 2020 with a 10:11 split ratio.
| Last Split Date | 11/26/2020 |
| Split Ratio | 10:11 |
Already premium?